4.5 Article

High-efficiency brain-targeted intranasal delivery of BDNF mediated by engineered exosomes to promote remyelination

Journal

BIOMATERIALS SCIENCE
Volume 10, Issue 19, Pages 5707-5718

Publisher

ROYAL SOC CHEMISTRY
DOI: 10.1039/d2bm00518b

Keywords

-

Funding

  1. Guangdong Basic and Applied Basic Research Foundation [2019B1515120090]
  2. National Natural Science Foundation of China [51903246, 31700831]
  3. Natural Science Foundation of Jiangsu Province [BK20201196]

Ask authors/readers for more resources

This study demonstrates the use of modified exosomes as carriers for brain-derived neurotrophic factor (BDNF), which promotes the differentiation of oligodendrocyte precursor cells (OPCs) into mature oligodendrocytes. Through intranasal administration, this method shows significant therapeutic effects on remyelination and motor coordination in demyelination model mice. Thus, this strategy of delivering BDNF via engineered exosomes provides a new approach for the treatment of central nervous system diseases.
The regeneration of myelin sheaths is the ultimate goal of the treatment of demyelination disease, including multiple sclerosis (MS). However, current drugs for MS mainly target the immune system and can only slow down the disease development and do not promote the differentiation of oligodendrocyte precursor cells (OPCs) abundant in the myelin injury region into mature oligodendrocytes to form a new myelin sheath. Brain-derived neurotrophic factor (BDNF) plays an important role in the regulation of OPC proliferation and differentiation into mature oligodendrocytes. Exosomes, a kind of nanoscale membrane vesicle secreted by cells, can be used as potential therapeutic drug delivery vectors for central nervous system diseases. Here, brain-targeted modification and BDNF intracellular-loaded exosomes were produced through engineering HEK293T cells, which can promote the differentiation of OPCs into mature oligodendrocytes in vitro. The intranasal administration of the brain-targeted engineered exosome-mediated BDNF was a highly effective delivery route to the brain and had a significant therapeutic effect on remyelination and motor coordination ability improvement in demyelination model mice. The combination of intranasal administration with brain-targeted and BDNF-loaded designed exosomes provides a strategy for efficient drug delivery and treatment of central nervous system diseases.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available